TRGQX Fees and Costs — T. Rowe Price Retirement 2070 Fund, R Class

Data updated: 2026-08-12

The net expense ratio is 1.14%: a 0.64% management fee plus a 0.50% 12b-1 fee. There are no sales loads or redemption fees. Portfolio turnover was 38%.

TRGQX Fees and Expenses

Annual operating expenses and sales charges of TRGQX. Prospectus, as of July 27, 2026.

Annual operating expenses
Management fee0.64%
12b-1 fee0.50%
Other expenses0.00%
Gross expense ratio1.14%
Fee waiver—
Net expense ratio1.14%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)No
Fees waived or reduced during the yearNo
Waived fees subject to recoupmentNo

TRGQX Costs Over Time

On $10,000 invested in TRGQX, assuming 5% a year before costs, total costs come to $711 over 5 years, cutting the return by 1.20% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 1.14%)$120$373$646
Lost growth on money paid in costs$0$18$65
Total costs$120$391$711
Value after costs$10,380$11,185$12,052
Impact on return, per year1.20%1.20%1.20%

TRGQX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending May 31, 2026.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 38%
  • Securities lending: none during the year

T. Rowe Price Retirement 2070 Fund Share Classes

Net expense ratio and maximum front-end load of each share class, cheapest first.

TickerClassNet expense ratioFront load
TRVQXI Class0.46%—
TRVSXT. Rowe Price Retirement 2070 Fund0.64%—
TRVTXAdvisor Class0.89%—
TRGQXR Class1.14%—

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.